Review Article
Antineutrophil Cytoplasm Autoantibodies: Usefulness in Rheumatology
Utilidad de los anticuerpos anticitoplasma de neutrófilo en reumatología
Luis Felipe Flores-Suárez
Clínica de Vasculitis Sistémicas Primarias, Instituto Nacional de Enfermedades Respiratorias, México D.F., Mexico
Read
8244
Timeswas read the article
2655
Total PDF
5589
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 6 | 6 | 6 | 12 |
| 2025 5 | 121 | 87 | 208 |
| 2025 4 | 113 | 33 | 146 |
| 2025 3 | 78 | 29 | 107 |
| 2025 2 | 80 | 26 | 106 |
| 2025 1 | 59 | 54 | 113 |
| 2024 12 | 33 | 30 | 63 |
| 2024 11 | 50 | 65 | 115 |
| 2024 10 | 36 | 30 | 66 |
| 2024 9 | 34 | 19 | 53 |
| 2024 8 | 47 | 28 | 75 |
| 2024 7 | 42 | 33 | 75 |
| 2024 6 | 55 | 31 | 86 |
| 2024 5 | 51 | 35 | 86 |
| 2024 4 | 65 | 22 | 87 |
| 2024 3 | 47 | 27 | 74 |
| 2024 2 | 32 | 23 | 55 |
| 2024 1 | 88 | 25 | 113 |
| 2023 12 | 31 | 32 | 63 |
| 2023 11 | 39 | 41 | 80 |
| 2023 10 | 29 | 43 | 72 |
| 2023 9 | 149 | 36 | 185 |
| 2023 8 | 27 | 18 | 45 |
| 2023 7 | 27 | 21 | 48 |
| 2023 6 | 27 | 29 | 56 |
| 2023 5 | 25 | 20 | 45 |
| 2023 4 | 15 | 6 | 21 |
| 2023 3 | 43 | 25 | 68 |
| 2023 2 | 39 | 28 | 67 |
| 2023 1 | 22 | 18 | 40 |
| 2022 12 | 45 | 31 | 76 |
| 2022 11 | 74 | 39 | 113 |
| 2022 10 | 84 | 30 | 114 |
| 2022 9 | 90 | 32 | 122 |
| 2022 8 | 48 | 42 | 90 |
| 2022 7 | 37 | 40 | 77 |
| 2022 6 | 36 | 31 | 67 |
| 2022 5 | 41 | 47 | 88 |
| 2022 4 | 44 | 56 | 100 |
| 2022 3 | 54 | 57 | 111 |
| 2022 2 | 28 | 25 | 53 |
| 2022 1 | 28 | 32 | 60 |
| 2021 12 | 23 | 34 | 57 |
| 2021 11 | 38 | 43 | 81 |
| 2021 10 | 39 | 59 | 98 |
| 2021 9 | 38 | 46 | 84 |
| 2021 8 | 30 | 43 | 73 |
| 2021 7 | 40 | 32 | 72 |
| 2021 6 | 45 | 26 | 71 |
| 2021 5 | 40 | 42 | 82 |
| 2021 4 | 65 | 54 | 119 |
| 2021 3 | 63 | 40 | 103 |
| 2021 2 | 53 | 25 | 78 |
| 2021 1 | 37 | 16 | 53 |
| 2020 12 | 28 | 22 | 50 |
| 2020 11 | 26 | 18 | 44 |
| 2020 10 | 18 | 10 | 28 |
| 2020 9 | 32 | 16 | 48 |
| 2020 8 | 27 | 15 | 42 |
| 2020 7 | 20 | 19 | 39 |
| 2020 6 | 34 | 23 | 57 |
| 2020 5 | 29 | 28 | 57 |
| 2020 4 | 34 | 20 | 54 |
| 2020 3 | 15 | 2 | 17 |
| 2020 2 | 1 | 0 | 1 |
| 2019 1 | 1 | 0 | 1 |
| 2018 5 | 5 | 0 | 5 |
| 2018 4 | 37 | 4 | 41 |
| 2018 3 | 47 | 5 | 52 |
| 2018 2 | 34 | 4 | 38 |
| 2018 1 | 24 | 2 | 26 |
| 2017 12 | 45 | 5 | 50 |
| 2017 11 | 30 | 3 | 33 |
| 2017 10 | 42 | 6 | 48 |
| 2017 9 | 27 | 12 | 39 |
| 2017 8 | 29 | 5 | 34 |
| 2017 7 | 37 | 3 | 40 |
| 2017 6 | 55 | 6 | 61 |
| 2017 5 | 59 | 4 | 63 |
| 2017 4 | 44 | 9 | 53 |
| 2017 3 | 56 | 4 | 60 |
| 2017 2 | 28 | 5 | 33 |
| 2017 1 | 37 | 8 | 45 |
| 2016 12 | 85 | 14 | 99 |
| 2016 11 | 51 | 3 | 54 |
| 2016 10 | 82 | 11 | 93 |
| 2016 9 | 85 | 6 | 91 |
| 2016 8 | 75 | 14 | 89 |
| 2016 7 | 36 | 5 | 41 |
| 2016 2 | 0 | 16 | 16 |
| 2016 1 | 1 | 0 | 1 |
| 2015 12 | 3 | 0 | 3 |
| 2015 10 | 6 | 12 | 18 |
| 2015 9 | 2 | 0 | 2 |
| 2015 8 | 3 | 0 | 3 |
| 2015 7 | 26 | 8 | 34 |
| 2015 6 | 41 | 7 | 48 |
| 2015 5 | 49 | 25 | 74 |
| 2015 4 | 41 | 13 | 54 |
| 2015 3 | 41 | 6 | 47 |
| 2015 2 | 48 | 10 | 58 |
| 2015 1 | 77 | 10 | 87 |
| 2014 12 | 41 | 7 | 48 |
| 2014 11 | 32 | 10 | 42 |
| 2014 10 | 49 | 10 | 59 |
| 2014 9 | 39 | 14 | 53 |
| 2014 8 | 45 | 9 | 54 |
| 2014 7 | 50 | 18 | 68 |
| 2014 6 | 73 | 16 | 89 |
| 2014 5 | 72 | 18 | 90 |
| 2014 4 | 62 | 19 | 81 |
| 2014 3 | 49 | 19 | 68 |
| 2014 2 | 41 | 16 | 57 |
| 2014 1 | 40 | 12 | 52 |
| 2013 12 | 44 | 9 | 53 |
| 2013 11 | 41 | 9 | 50 |
| 2013 10 | 38 | 9 | 47 |
| 2013 9 | 45 | 9 | 54 |
| 2013 8 | 48 | 21 | 69 |
| 2013 7 | 50 | 7 | 57 |
| 2013 6 | 43 | 10 | 53 |
| 2013 5 | 41 | 16 | 57 |
| 2013 4 | 40 | 30 | 70 |
| 2013 3 | 65 | 20 | 85 |
| 2013 2 | 68 | 20 | 88 |
| 2013 1 | 73 | 25 | 98 |
| 2012 12 | 109 | 35 | 144 |
| 2012 11 | 8 | 7 | 15 |
Show all
